The Institute of Cancer Research, London, welcomes the news that a new targeted breast cancer drug, capivasertib, has been approved by the Medicines & Healthcare products Regulatory Agency (MHRA) for ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.
The Institute of Cancer Research, London, strongly welcomes the news that a new targeted breast cancer drug, capivasertib, has been approved by the US Food and Drug Administration (FDA) for treating ...
A company that is changing the outlook on pancreatic cancer has more promising data for treatments near-term and for a ...
A groundbreaking study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC). The findings ...
More than 100 million Americans are living with obesity, and deaths from 13 types of cancers related to the condition have tripled over the past two decades. Earlier studies have suggested a link ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results